Donafenib combined with capecitabine for postoperative adjuvant therapy of biliary malignant tumors with high risk of recurrence: A multi-center, randomized controlled, phase II study.

Authors: Jianhua Rao, Yongquan Chi, Long Zhang, Yong Yang, Hailong Ge, Weixin Yu, Jing Huang, Feng Cheng

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4223

Source: Full article


Abstract

TPS4223